KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Net Cash Flow (2018 - 2026)

Castle Biosciences' Net Cash Flow history spans 8 years, with the latest figure at $31.2 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 25.95% to $31.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.0 million, a 114.28% decrease, with the full-year FY2025 number at -$3.0 million, down 114.28% from a year prior.
  • Net Cash Flow hit $31.2 million in Q4 2025 for Castle Biosciences, up from $3.3 million in the prior quarter.
  • Over the last five years, Net Cash Flow for CSTL hit a ceiling of $31.2 million in Q4 2025 and a floor of -$139.0 million in Q3 2022.
  • Historically, Net Cash Flow has averaged -$14.7 million across 5 years, with a median of -$7.8 million in 2023.
  • Biggest five-year swings in Net Cash Flow: tumbled 2592.48% in 2022 and later skyrocketed 301.83% in 2024.
  • Tracing CSTL's Net Cash Flow over 5 years: stood at -$33.5 million in 2021, then surged by 66.52% to -$11.2 million in 2022, then skyrocketed by 167.82% to $7.6 million in 2023, then skyrocketed by 224.89% to $24.8 million in 2024, then rose by 25.95% to $31.2 million in 2025.
  • Business Quant data shows Net Cash Flow for CSTL at $31.2 million in Q4 2025, $3.3 million in Q3 2025, and -$7.5 million in Q2 2025.